key: cord-0981703-0dageghm
authors: nan
title: Additive Manufacturing for Localized Medical Parts Production: A Case Study
date: 2021-02-01
journal: IEEE Access
DOI: 10.1109/access.2021.3056058
sha: 09268ce91938570efe9a4d03b3db022291b7e377
doc_id: 981703
cord_uid: 0dageghm

Centralized supply chains (SCs) are prone to disruption, which makes them a risky choice for medical equipment production. Additive manufacturing (AM) allows for production localization and improvements in SC resilience. However, the comparative competitiveness of a localized SC from the time and cost perspective is still unclear. In this study, we investigate the competitiveness of localized medical part AM SCs against centralized ones by analyzing the responsiveness and cost of each SC. We utilize a real-world case study in which an AM service provider supplies medical parts to university medical centers in the Netherlands to construct six scenarios. We also develop a thorough empirical cost formulation for both central and local AM of patient-specific medical parts. The results of scenario analysis show that when utilizing the currently available AM technology, localized SC configurations significantly reduce the delivery time from about 54 to 27h, but at a 4.3-fold higher cost. Hence, we illustrate that the cost difference between the localized and centralized scenarios can be reduced when state-of-the-art AM machines are utilized, demand volumes increase, and the distances between the SC network nodes expand. Moreover, our scenario analysis confirms that the cost of the measures taken to prevent dust dispersion associated with powder-bed fusion AM has a major impact on the total cost of localized AM SCs for medical parts. The results of this study contribute to the understanding of the relevant factors in deciding whether central or localized SC configurations can be used in the AM production of medical parts. Furthermore, this study provides managerial insights for decision-makers at governments and hospitals as well as AM service providers and AM equipment manufacturers.

Centralized supply chains (SCs) are among the main sources of efficiency and cost-effectiveness in today's global economy. However, events such as pandemics and natural disasters have illustrated the weaknesses of centralized SC designs [1] . In 2011, during Thailand's floods and Japan's earthquake and tsunami, major disruptions occurred in the SC of items such as computer hard disk drives and automotive parts, respectively. A similar but larger impact was registered during the early stages of the COVID-19 pandemic in 2020,

The associate editor coordinating the review of this manuscript and approving it for publication was Shunfeng Cheng.

which impacted the availability of medical parts, including products that are critical in the fight against the pandemic, such as test swabs and personal protective equipment [2] . In such situations, flexibility in the manufacturing and SCs proves to be very valuable [3] . In some cases, SC flexibility is developed using local digital manufacturing solutions [4] . In this study, we explore the justification and feasibility of such localization decision for additive manufacturing (AM).

AM is a direct digital manufacturing technology in which material is added layer by layer, in contrast to traditional (subtractive) manufacturing, in which material is gradually removed from an initial block to achieve the intended shape [5] . In general, AM allows for the production of complex geometries and mass customization without incurring additional costs. In [6] , the authors describe how AM can be disruptive in one context while causing only minor changes in another, whereas in [7] , [8] , AM is viewed as useful for particular applications. In [9] , several examples of potentially disruptive effects on SCs are provided, for instance, when manufacturing in low-wage countries moves from factories to households. Generally, AM is suitable for in situ (local) manufacturing since digital files easily bypass physical boundaries [10] , [66] . During the early phase of the COVID-19 pandemic, AM was used locally to alleviate the scarcity of nasal test swabs, confirming the risks related to centralized manufacturing SCs for basic medical parts. The conventional manufacturing of nasal test swabs was centralized in Italy, thus causing severe difficulties to ramp up testing in different countries worldwide and, hence, worsening the situation with regard to the pandemic. According to [11] , localized AM supported the alleviation of the shortage of swabs for testing, illustrating the use of AM for SC resilience improvement.

AM is used in many medical applications, such as preoperative models, implants, tools, and instruments [12] . Some of these applications are still in the research phase, but others are already commercially available. In line with [13] , in which it was mentioned that the use of direct digital prototyping may accelerate and simplify in-house design, several university medical centers (UMCs) in the Netherlands have sought to improve the treatment quality. Increasing the speed of feedback, as a result of switching from centralized to localized AM, of patient-specific medical care products helps improve the ''experiential learning'' [14] . In this study, we investigate the situation in different UMCs throughout the Netherlands to understand the impact of localized AM SCs on the responsiveness of medical parts and economics of such implementation. The findings provide relevant managerial implications in guiding the preparation efforts before and during a pandemic.

The remainder of this article is organized as follows. In Section II, we review the current literature. In Section III, we describe the research methodology, followed by the results in Section IV, a discussion in Section V, and the conclusions in Section VI.

This section introduces the relevant SC concepts and examines those related to AM. It also explains the effects of AM on SC design and defines the gap in the literature.

Supply chain management (SCM) is a management field that has originated in logistics [15] . While logistics mainly focuses on the flow of materials, SCM takes a more holistic approach and includes the flow of information and money. With the emergence of the supply chain operations reference (SCOR) model [16] , SCM definitions have been standardized, thus simplifying the benchmarking of processes and performances. In general, the performance of an SC is measured from its outcomes. In this study, we focus on the traditional SC outcomes of cost and responsiveness according to the SCOR definitions. Costs are defined as the total SC management costs (i.e., the sum of the costs associated with planning, sourcing, making, delivering, and returning orders). Responsiveness is defined as the order fulfillment cycle time, the time from order receipt to order acceptance [16] .

Having a well-designed SC is strategically vital for a firm's competitiveness [9] . Each SC design comprises choices related to manufacturing, inventory, assortment, personnel, information and communications technology, and transportation modalities [17] . In this study, we explore one of the most important decisions in SC design: when to switch from centralized to localized SC configurations.

SC designs are heavily influenced by technological and societal changes. According to the World Economic Forum, society is on the verge of the fourth industrial revolution [18] , whereby increasingly fast computing, for instance, mobile supercomputers and artificial intelligence (AI), is revolutionizing civilizations. Computer technology is increasingly penetrating and digitizing SCs. In [19] , a digital SC was defined as ''a smart and value-driven process that generates business value with analytical processes and technology.'' In addition to AM, digital SCs can include any other digital technology, for instance, AI, blockchain technology, Internet of Things, automated guided vehicles, or combinations of technologies, for instance, in the context of a ''digital twin'' [20] .

AM is a collection of techniques that can, depending on the material and specific technology chosen, be categorized in different ways [5] . In this study, we focus on selective laser sintering (SLS), which is a powder-bed fusion (PBF) AM technique. AM is also known as rapid prototyping (RP), rapid tooling (RT), rapid manufacturing (RM), and three-dimensional (3D) printing. After the invention of AM, prototyping (RP) applications were the first to appear in the 1980s. As more materials became printable, tooling (RT) applications followed in the late 1980s. In [21] , RP and RT are considered as fully mature applications, which is in contrast to the RM of final products. Nevertheless, various use cases for the AM of final parts already exist, for instance, for industrial spare parts [22] , [23] , for patient-specific medical applications [24] , [25] , for consumer products [26] , [27] , and for art, hobbies, jewelry, and fashion [28] .

AM has several benefits over subtractive manufacturing, although there are also potential downsides to this process. Such benefits include the potential integration of functions into the design (e.g., cooling channels), or part consolidation while benefiting from a less restrictive design for manufacturability requirements. The benefits of AM also include the absence of tools in the production process, which enables the production of very small batches of parts. Moreover, because of its layer-wise process, AM can significantly reduce raw material waste, particularly in metal PBF AM, compared to conventional manufacturing methods, such as computer numerical control machining. The downsides of AM include the fact that the production speed may be low, the machines and materials may be expensive, the automation levels during the pre-and postprocessing of 3D-printed parts may be low, and the surface finish of the parts may be poor. Moreover, no standards have yet been fully developed for AM, which limits its utilization in different industries, such as nuclear powerplants [29] - [32] .

It should be noted that the ability of AM to produce any desired shape makes it suitable for personalized medical products [33] , [34] . For example, it has been shown that the availability of a digital file can improve the replicability of personalized hearing aids [35] , preoperative models can be used as a communication tool to improve trust and consent [25] , [36] , implants can speed up surgeries [37] , and in-operating-room on-demand AM of coronary stents can significantly reduce the SC lead time [38] .

It should also be noted that the unique characteristics of AM change the requirements for SCs while potentially improving the SC performance [39] . Compared to traditional (subtractive) manufacturing, AM may make SCs shorter and simpler, thus reducing the number of SC steps [40] , [41] , [42] , and digital file distribution may largely replace the distribution of goods [10] , [43] , [7] . Moreover, the traditional design-build-deliver arrangement may shift [44] .

In general, SC configuration decisions consist of the positioning of AM in the SC [45] . Centralized configurations do exist [46] , [47] , [48] , as well as localized AM configurations, which are also called ''distributed,'' ''in situ,'' or ''decentralized'' configurations [13] , [26] . Centralized design combined with localized manufacturing has also been mentioned in [35] , in contrast to [49] , in which localized scanning was combined with centralized manufacturing. In [46] , centralized coordination was combined with localized manufacturing, whereas in [50] , centralized control with different levels of localized automation was described. However, only one of these studies contributes to the SC design analysis of medical parts [24] .

In [24] , [51] , the authors studied the implementation of AM in localized SC configurations. Localized AM may improve responsiveness (speed), yielding, for example, a shorter repair time, shorter time to market, and faster product availability [43] , [51] , [52] . For the SCs of medical parts, a significant reduction of the SC lead time is envisioned [35] , [38] . Localized AM may reduce inventory (finished goods) and transportation costs [49] , [53] . However, compared to the centralized solutions offered by AM service providers, localized locations have no economies of scope in terms of equipment utilization, raw material purchasing, labor, and knowledge [7] , [23] .

Recently, there has been an increase in the academic literature on the effects of AM on SC designs [7] , [42] , [51] , [54] , [55] .

For example, the study in [45] describes the centralized versus localized positioning of AM in SCs and the related cost and responsiveness tradeoffs as a key research topic in SC design. In [51] , [54] , the authors investigated central versus localized configuration decisions regarding spare parts' SCs. In [24] , the authors investigated the economic feasibility of switching from traditional manufacturing to in situ AM of biomedical implants.

Among research articles on the use of AM in medical applications, only a few have utilized real-world case study material (see, e.g., [24] , [35] ). However, these articles are generally exploratory in nature or they compare AM with traditional manufacturing and do not compare SC configuration decisions within an already existing AM SC design. The aim of this study is to contribute to the filling the gap of knowledge regarding central versus localized medical SCs by studying a real-world SC in which an AM service provider supplies patient-specific medical care products to UMCs. Our contribution is, hence, to provide insights into the key decision-making factors related to switching from a centralized to a localized SC design configuration, considering the tradeoffs in SC responsiveness and cost performance. This research will help inform decision-making and provide opportunities for interventions at medical centers, AM service providers, and AM equipment manufacturers. The following are the research questions (RQs) that we aim to answer in this study: RQ1: What is the comparative competitiveness of centralized versus localized AM SC configurations for patient-specific medical parts from the viewpoints of responsiveness and cost? RQ2: How does the comparative competitiveness of centralized versus localized AM SC configurations change when technology improves, demand volume changes, and/or service distance increases?

In this study, we use data acquired from a real-world case study (explained in Section III.A) and scenario analysis (explained in Section III.B) for evaluating the impact of current and future AM machines on the SC responsiveness and cost of centralized and localized patient-specific medical parts' SCs. Our methodological design is summarized in Fig. 1 . 

In [56] , case study research is defined as ''an empirical inquiry that investigates a contemporary phenomenon (the case) in depth and within its real-world context.'' In this study, we followed the guidelines of [56] for data collection to ensure research rigor. We selected AM cases of patient-specific medical parts to contribute to the body of knowledge regarding the SC design for medical applications. According to [56] , cases should be analytically generalizable, and this case represents a wide class of AM applications in a medical context.

In this study, we investigate the SCs of patient-specific surgical guides, which are used with cutting or drilling tools and allow for preoperative planning (Fig. 2) . These personalized guides enable surgeons to plan the exact positioning for cutting and drilling the patient's bones prior to the actual surgery. In general, being able to personalize these guides means that an improvement can be achieved in terms of surgery quality and first-time fit. Besides improving the patient's wellbeing, this may save up to 1 hour of operating room (OR) time. In general, AM is very suitable for manufacturing such complex shapes and has been used for this purpose for several years now. A set used during surgery can consist of multiple pieces. Currently, the SC is comprised of eight UMCs located in the Netherlands, where these surgeries are performed. These UMCs are supplied by one (central, outsourced) AM service provider, also located in the Netherlands. This AM service provider uses EOS P100 AM machines, which employ the polyamide SLS PBF process [57] . Being the legal manufacturer, the UMC innovation lab uses computed tomography scan Digital Imaging and Communications in Medicine data to design surgical guides and then forwards the files for manufacturing to the AM service provider. After the manufacturing process, the lab receives the manufactured part, checks its quality, sterilizes it, and hands it over to the physician for surgery. Our case study research started with the selection of input parameters to calculate the cost and responsiveness. Data were collected from one of the UMCs interested in localizing the AM of these surgical guides. To achieve such a localized SC configuration, each UMC requires on-site AM production.

The data collection process followed the approach outlined in [56] , using logical models and time study maps for analyzing case study evidence. To make sure data were collected on all the relevant processes, an interview question protocol was developed [56] . For each SC step, data on the volume, time, and cost were gathered, allowing the calculation of the cost and responsiveness outcome measures.

The AM service provider's chief executive officer (CEO) served as the primary source of information concerning the service provider's processes. Observational data, enterprise resource planning data, and employee interview data were also collected, and video conference interviews were conducted with an engineer at the UMC innovation lab. The transcripts of the taped interviews were then verified by the interviewees, and this information was then used for drafting the current processes (base case; see Appendix A). All the collected data and process maps were validated by the interviewees and used to develop and calculate the future scenarios outlined in the next section.

Scenario analysis [58] can help identify and evaluate realistic future options [59] . In [51] , [54] , scenario analysis was used to investigate SC optimization by comparing centralized versus localized configurations in an industrial spare parts context. As suggested in [60] , we used a three-step approach for strategic SC planning. In the first step, scenarios were built. In the second step, two scenarios were planned (i.e., calculations were made). In the third step, the scenarios were validated by the researcher and by the field representatives before being utilized to generate the results.

Candidate scenarios were identified, and the key influencing factors were determined [60] . We varied the SC configurations between centralized and localized AM production. As the second scenario variable, we utilized the current and future states of technology. In scenarios, the current state of AM technology refers to the use of the EOS P100 SLS machine. The specifications of the Future 1 AM machine are based on the upcoming Formlabs Fuse One AM machine. The specifications of the Future 2 AM machine are also based on the Formlabs Fuse One but with the assumption of dual-chamber automated operation capability to eliminate out-of-machine cooling and the need for cleanroom. It should be noted that the specifications of the Formlabs Fuse One machine are comparable with those of the EOS P100 and that this machine has been verified for medical devices processing and materials. However, it has a smaller production chamber and a less powerful laser [61] . Our six distinct scenarios are presented in Table 1 .

We also investigated the effects of demand changes, different numbers of service locations, and service distance on the competitiveness of the scenarios using sensitivity analyses. This is detailed in Sections IV.A and IV.B.

In four iteration rounds, the scenarios and calculations were refined and discussed with the AM service provider's CEO until a final consensus was reached and scenario models were verified. To keep the model simple, possible wastes (e.g., waiting times) were ignored and responsiveness and cost modeling considered delivery to the UMC as the end- • Transportation (outsourced): shipping of finished goods. The sum of the steps was calculated for the average demand for a period of five years in hours using the formula, as shown at the bottom of the page.

The following total SC management cost elements were included in our SC cost model:

• Equipment: AM machine investments and maintenance as well as investments in postprocessing equipment (blaster, brush).

• Facilities: facility adaptations (foundation preparation, air conditioning, and air cleaning). Space acquisition or rental costs were excluded.

• Labor: operator training and operational costs, as well as supervisor costs (one supervisor per six operators).

• Material: polyamide raw material.

• Utilities: energy for preheating and manufacturing.

• Transportation (outsourced): finished products from the AM service provider to a UMC. To allow the comparison of the scenarios, we calculated the cost per part in Euros (e) and used the total SC cost over a five-year period divided by the cumulated five-year volume. The following formula was used to calculate the SC cost, as shown at the bottom of the page.

Microsoft Excel was used for SC modeling and total cost calculation of the scenarios. For more details regarding the data used for the creation of the scenarios, please refer to Appendix B.

Section IV.A presents the results of our detailed empirical cost formulation and contributes to a broader agenda related to the development of a decision system. In Section IV.B, we present the findings of the scenario analysis on cost and responsiveness for producing patient-specific medical parts. In Sections IV.C, IV.D, and IV.E, we perform a sensitivity study on important variables, including the number of service locations, demand level, and service distance.

On the basis of our case study, two cost models were formulated to be used by SC practitioners. A centralized AM annual SC cost formulation for the manufacturing of medical parts (EQ1) is presented first: In the cost model for the centralized AM SC, the decision parameters are n AM , n PPM , n OP , n S , n AT , in addition to the type of AM process that can significantly impact the A, and WR. For instance, a centralized operator can decide to have a larger AM machine so that it can accommodate the growing demand, or perhaps the operator may decide to start with machines with smaller production chambers and increase the number of the machines with the expansion of the business. These decisions impact the short-and longterm competitiveness of a centralized SC against a localized AM SC.

The localized AM annual SC cost formulation for the manufacturing of medical parts (EQ2) is presented as follows: In the EQ2 cost model for localized AM SCs for patient-specific medical parts, we can see the main differences with EQ1. The cost of transportation is eliminated because of the local production of demand. Moreover, n L is added to the decision parameters of the localized AM SC.

Both EQ1 and EQ2 are among the main empirical contributions of this research, allowing SC practitioners to accurately model the cost of their SC for centralized and localized implementation of AM for patient-specific medical parts. We also determined the parameters that can be tweaked to enhance the decision-making process. Fig. 3 presents the results of SC responsiveness for the six scenarios. The results show that the localized scenarios (2, 4, and 6) perform better on SC responsiveness, whereas the centralized scenarios (1, 3, and 5) perform better on SC costs ( Table 2) . It should be noted that such better performance of the localized SC scenarios with regard to responsiveness is mainly due to the elimination of the 24h transportation time between the point of production and demand location. The remaining 27.1h response time of Scenario 4 (localized) is mainly attributed to the 22h cooling time (2h inside plus 20h outside the AM machine) required to ensure product quality and accuracy by reducing warping. It was also observed that the manufacturing time of Scenario 4 is longer than that of Scenario 2 because of the smaller chamber capacity in Formlabs Fuse One and lower laser power. However, the quick responsiveness of Scenario 6 is due to the elimination of the long cooling time outside the machine, enabled by the hypothetical Future 2 AM machine. More information is provided in Appendix C. If a UMC, bearing in mind the technological advances that will be made in the near future using Formlabs Fuse One, has to decide between centralized and localized SC configurations, Scenarios 1 and 4 should be compared. This comparison shows that the unit cost of the localized SC configuration is almost three times higher than that of the centralized SC configuration, with half the SC responsiveness. Moreover, the cost per part in Scenarios 2 and 4 with localized SC configurations is 4.3 and 4.2 times higher than in Scenarios 1 and 3 (centralized AM SC) while using current and future AM machines, respectively. The results show that while the SC responsiveness is slightly reduced with the use of a future AM machine (because of the lower-powered laser in comparison to the current AM machine), the cost competitiveness improves by 57%.

Interestingly, the costs of Scenario 6 are close to those of Scenario 1 (e6.4/unit cost difference). This illustrates the importance of cheaper AM machines with automated internal part cleaning capabilities when considering the cost-effectiveness of localized SCs. Moreover, it was found that Scenario 6 is nearly 46.5h faster than Scenario 1. Fig. 4 illustrates the major cost components of each scenario and shows that the machine costs are significantly lower for Scenarios 3 and 4 (future AM) than for Scenarios 1 and 2 (current AM). This is due to the high purchase price of the EOS SLS AM machines at e250K. In general, the costs of the space adjustments are very high in the localized SC scenarios as compared to the centralized SC scenarios. This is mainly due to the high costs required to adjust the eight facilities to prevent the dust dispersion caused by production and postprocessing activities (cleaning and tumbling). The magnitude of this problem becomes more evident when visiting an AM service provider using this SLS/polyamide technology, where the production areas are covered by a thin layer of dust. This is particularly unacceptable in a hospital context, and hence dust-prevention measures are required, such as air-tightening the facilities and installing air-cleaning equipment. In consultation with the AM service provider's CEO, these facility adaptations are estimated to cost e85K per hospital (including the foundation preparations).

It was also observed that the transportation costs are high in the centralized scenarios, at e3.9/unit, but nonexistent in the localized SC scenarios and that the absolute cost for raw materials (including raw material shipping) is identical, at e2.3/unit, for all six scenarios. Moreover, the personnel costs are significantly lower in the centralized SC scenarios, at e3.7/unit and e3.3/unit, than in the localized scenarios, at e16.2/unit and e12.9/unit, respectively. The reason for such a vast difference is that, in the localized setting, assuming an equal uniform distribution of the demand volume over the locations, the total number of machine runs increases. This causes an increase in the overall number of hours of work. Moreover, having the AM machines in eight different locations means that there is a need for eight times the initial personnel training. The difference in the postprocessing costs between the current and future AM machine scenario results from cutting equipment costs in half, e5K per location, which is then multiplied by the number of locations. In all scenarios, the energy costs have no significant impact on cost performance.

In our case study, there are eight university hospitals that require AM medical parts. However, to understand the impact of larger and smaller numbers of service locations, we performed a sensitivity analysis. In total, two, four, 12, 15, and 20 university hospitals were used for the sensitivity analysis of production cost per part for all six scenarios. As shown in Fig. 5 , the three localized scenarios show a larger cost increase than that in the centralized SC scenarios, in which the cost per part increases only slightly. While the cost per part for Scenario 1 increases by only 14.7% when the number of university hospitals increases from two to 20, the cost per part for Scenario 6, which is the most cost-competitive among the localized scenarios, increases by more than 434%. This is mainly due to a large increase in the equipment and facility costs. An interesting finding from this sensitivity analysis is that Scenarios 4 and 6 are cost-competitive with Scenario 1 when two and four university hospitals, respectively, are served (Table 3 ) . 

To further understand the impact of demand changes on the SC responsiveness and cost, we performed a sensitivity analysis on demand for Scenarios 1 to 4. Figures 6 and 7 illustrate the results of changes in the overall market demand volumes for the demand levels of 2400, 4960, 7440, 14880, 29760, and 59520 units. Increasing the demand does not significantly change the responsiveness of the localized scenarios because of the existence of a significant capacity buffer. However, the responsiveness of the centralized AM SC is reduced by 19.5% and 27.3% for Scenarios 1 and 3, respectively, when the demand quadruples from 14880 to 59520 units. The main source of this reduced responsiveness is the increased production time on the AM machine, since a higher demand requires more parts to be printed during each run, potentially increasing the height of the print and consequently causing longer print times on the available machine. costs decrease by 72% (Scenario 2) and 70% (Scenario 4) in the localized scenarios. These high unit costs at low volumes are caused by poor machine and production chamber utilization.

In general, when using the SLS technique, increasing the ratio between the powder and the parts (packing density) is crucial for improving the manufacturing time and cost per part [62] . This results in the need to make as many parts as possible during each production run [63] . In a higher-demand setting, it is possible to take advantage of the empty chamber to produce more parts and, therefore, reduce the overall cost per part. The mechanism underlying this event is that the costs of both pre-and postproduction activities are divided by a larger number in an increased-demand setting. Moreover, in the SLS process, as long as the height of the print job is constant while filling up the chamber, the time required for preheating and recoating each layer is divided by a larger number of parts, which also contributes to a lower cost per part. In summary, higher demand volumes improve the competitiveness of localized AM in comparison to the centralized patient-specific medical parts AM SC configuration in terms of both responsiveness and cost.

To improve the generalizability and make our results applicable to large countries, such as the United States, China, Brazil, and Canada, we scaled up the transportation distances to cover some of the main cities of Europe (see Fig. 8 ).

We assume that the manufacturing facility in the Netherlands supplies medical products to UMCs in Amsterdam as well as in Berlin, Paris, Vienna, Copenhagen, Stockholm, Prague, and Milan. Scenarios 1 , 2 , 3 , and 4 were modeled for the intra-European context (Table 4) . We extracted the cost and time of intra-European transportation from the webpage of DHL International [64] , and we utilized an express delivery service with a delivery time of 24h (delivery at the end of the next day for items posted before 6:00 PM).

Since it was assumed that the demand follows a uniform distribution, the average cost of shipping to the eight destinations has been used. It was found that the average cost is approximately five times higher than the cost of transportation inside the Netherlands (e3.9 versus e18.5). Moreover, as an assumption and to compensate for the longer shipping distances for the localized scenarios, we increased the cost of raw material (which also includes the raw material's transportation cost) by 20%.

The results showed that, for the intra-European service provision, the responsiveness of the localized scenarios is two times faster than that of the centralized scenarios, which have not changed from the original scenarios (Scenarios 1, 2, 3, and 4). This is because the delivery time between the selected cities is still nearly 24h. However, because of the increased transportation cost, longer distances increase the cost of centralized SCs by 55% and 83% for Scenarios 1 and 3 , respectively. For more details refer to Appendix C.

The findings presented in Table 4 illustrate that the cost competitiveness of the localized AM scenarios significantly increases as the distance between the customer and the point of production increases. It can also be observed that the difference between the total costs of Scenarios 3 and 4 shrinks by 25% when the distance increases. However, Scenarios 2 and 4 (localized) are still 2.8 and 2.3 times more costly than Scenarios 1 and 3 (centralized), respectively, for the demand levels used in this research. However, in the case of a pandemic, considering the consequences of lacking medical parts, this might not be a significant cost difference. The major cost components that contribute to the higher total cost of localized AM production are related to the costs of creating a certified space for production, machine cost, and cost of required personnel.

In this section, we discuss the implications of the findings, managerial contributions, and generalizability of this study and also point out its limitations.

It has been proven that the SC responsiveness of localized AM is two times higher than that of centralized AM for medical parts while costing 2.3 times more in an intra-European context. Such an extra cost can be justified since the unavailability of time-critical medical or nonmedical products may cause significant losses. In a nonmedical context, this preventable loss is referred to as the equipment downtime cost, and companies generally implement inventory management tools to circumvent this issue, including keeping a safety stock and setting a reordering point. However, when it comes to personalized medical parts, such inventory tools and policies do not apply since there is no stock of patient-specific parts. In this case, the SC responsiveness is related to the process of order placement, production, and transportation.

Interestingly, the results of the sensitivity analysis of the number of service locations (Fig. 5) showed relative cost competitiveness of Scenarios 4 and 6 with Scenario 1 when the number of locations served was only two. When the number of locations increased to 4, Scenario 6 was found to still be cost-competitive with Scenario 1. These findings can be interpreted in three ways. First, using smaller and lower-cost AM machines is preferable for localized AM. Second, the postprocessing and dust-dispersion costs in PBF technologies are a major obstacle for localized SCs and should be addressed to increase the cost competitiveness of localized AM. Third, other technologies, such as fused deposition modeling (FDM), that do not require significant postprocessing may be a potent candidate technology for localized AM of medical parts.

For time-critical medical parts (e.g., parts necessary for a traumatic situation), localized production can reduce the risks of late part delivery by eliminating the shipping time, hence reducing the risk of irreversible damage to people's lives. This becomes even more pronounced in the case of a pandemic. During a pandemic, similar to the current COVID-19 pandemic, SCs are disrupted because of the difficulties related to production and shipping. In such a setting, a centralized SC is more likely to be disrupted than a localized SC, since it relies on the shipment of items to different cities around a VOLUME 9, 2021 country or to different countries. Therefore, the cost premium paid for establishing a localized SC can be fully justified considering the lower risk of supply interruption and the possibility of increasing the production rate to meet the timecritical local medical demand. In this way, a localized SC may be very suitable for critical medical parts, especially during SC disruption, while also providing a production capacity buffer that can be used in the case of a pandemic [51] .

Among the parameters that can improve the cost competitiveness of localized AM are increasing demand and lower AM machine prices coupled with improved pre-and postproduction automation of the AM process. The total cost of a centralized AM SC with a similar affordable and automated AM machine will still be lower than that of a localized SC, but the total cost gap between the two SC configurations decreases.

In general, the findings of this research are transferable to any time-critical AM application under the condition that there is no stock keeping, which is inherent to personalized products. Such a crucial difference between patient-specific surgical guide SCs and industrial spare parts SCs does not allow the findings of this research to be used in applications with stock keeping [56] . However, our findings, modeling, and calculation methods are transferable to contexts without inventory holding, such as the production of other patient-specific medical care products (e.g., molds for implants, splints, and sight models). Moreover, we included two different SC scales in this study: one modeled inside the Netherlands, which is a relatively small country, and the other modeled on a European continent scale, which is comparable to any large country in the world. Therefore, by expanding the analysis to include both large-and small-scale SCs, these research findings can be transferred to large countries, such as the United States, China, Brazil, and Canada.

The fact that this research focuses on a country and a continent that have a well-developed infrastructure and logistics can be considered a limitation of this research. Future research should focus on the comparative competitiveness of AM SC configurations in countries and regions with developing or underdeveloped infrastructures. Moreover, we encourage studies on and comparisons of AM SC configurations for standardized medical components similar to the ones produced during the COVID-19 pandemic, such as nasal swabs, face shield holders, and Venturi valves [2] .

Additionally, we recommend that future research address the integral cost savings resulting from reduced OR utilization and hospitalization, as well as employer and societal cost benefits resulting from patient recovery due to localized AM. Here, we investigated the impact of mitigating the challenges rising from the dust dispersion of PBF processes in Scenarios 5 and 6 with promising outcomes. This can be considered an area of open investigation aiming to enhance the (post)production processes of PBF processes and achieve better dust dispersion and faster cooling processes. We also recommend conducting additional research on the use of other AM processes, such as FDM for the localized production of patient-specific medical parts.

Improvements in the cost competitiveness of localized AM SC configurations heavily depend on technological developments and the volume of demand. Therefore, the following are some recommendations for managers and business practitioners:

• To evaluate the cost competitiveness of localized AM SCs with a centralized AM SC for patient-specific medical parts, both EQ1 and EQ2 as well as the decision parameters presented in this research can be utilized.

• When the volume of demand for personalized medical parts increases and more affordable SLS AM machines enter the market, a localized SC can become highly competitive with a centralized configuration, particularly when the shipping methods are unreliable or the distance between the production site and the utilization location is large.

• Developing AM equipment that enables faster production and can offer new solutions for the dust-dispersion issue will allow for the localized use of equipment since it improves the SC responsiveness of localized SCs while also reducing the centralized versus localized SC cost gap. Moreover, AM machines with higher automation in the postprocessing steps can contribute to the competitiveness of localized AM for medical parts because the savings resulting from having fewer AM machine operators will be multiplied by the number of nodes in a localized SC.

• Since high chamber utilization is important to lower the cost of AM, companies can explore various solutions, such as the use of hub configurations (instead of fully self-owned localized AM), to improve the economic feasibility for noncritical medical parts. Moreover, for the production of time-critical medical parts in localized AM, the cost competitiveness can be enhanced by sacrificing an acceptable amount of responsiveness to pack the chamber with other less essential medical parts (e.g., molds for implants, sight models).

• It is worth noting that if a decision to switch from centralized to localized AM is made, centralized AM will continue to exist while localized AM will gradually fade in.

In general, the results obtained in this study contribute to the limited body of knowledge regarding the decision-making process for SC configurations of additively manufactured medical parts. Such a contribution is achieved by developing two cost formulas based on a real-world case study. Moreover, six scenarios were utilized to shed light on the technological and operational challenges of introducing localized AM to medical centers and hospitals. We investigated the responsiveness and costs of meeting the demand for patient-specific medical parts in centralized and localized AM SC configurations. An empirical cost model was developed for both centralized and localized SCs for producing patient-specific medical parts. The findings showed that, compared to the current centralized SC configuration, the localized scenario with soon-available technology halves the delivery time, but the costs are 4.3 times higher. Accelerated delivery of parts is possible because transportation is no longer necessary in a localized SC configuration. One of the main underlying components contributing to the current AM SC responsiveness is the long cooling-down time needed to prevent product warping. Regarding the major cost components of localized AM, we identified the AM equipment cost and the cost of the measures taken to prevent dust dispersion. Both issues of long cooling time and dust dispersion are due to the SLS AM technology, which can be addressed by the advancement of AM processes and material technologies in the future. Moreover, increasing the demand improves the SC responsiveness and cost competitiveness of localized scenarios compared to centralized ones. Both the COVID-19 pandemic and the subsequent disruptions in the supply of goods and standard medical equipment illustrated the importance of SC resilience and responsiveness. In particular, when the lack of time-critical patient-specific medical parts causes a stagger in the medical care processes, thus potentially causing irreversible damage to people's lives, localized AM can be used. Overall, decisions regarding the configuration of AM SCs (centralized versus localized AM SCs) are strongly interrelated with the time criticality of the medical parts, demand volumes, and technological advancements of AM machines. This study shows that although the SC cost of localized AM is higher than that of centralized AM, the lead-time improvement of localized AM is significant. It should be noted, however, that the scope of the present study did not include, for example, insurance-and employer-related issues, such as the potential reduction in sick leaves. Hence, it is safe to say that the potential integral cost savings that can be achieved by accelerating the medical care process may offset any additional unit costs associated with localized AM.

Moreover, the article processing charge was paid by DiDiMinH project. VOLUME 9, 2021 

In this appendix, we present the data collected from our realworld case study and the assumptions made for the creation of the scenarios (Tables 5, 6, and 7). We also discuss the calculation method of AM SC responsiveness and the cost for the scenarios. See table 5.  See table 6.  See table 7 .

In this appendix, we present a breakdown of our responsiveness (Table 8 ) and cost ( He has published more than 70 (scientific and popular) publications and has over 5000 citations in GoogleScholar. He also worked for Tebodin Consultants and Center for Applied Research and acts as a reviewer for international scientific journals.

MIKA SALMI is currently a Research Scientist with the Department of Mechanical Engineering, Aalto University. He has published extensively in the field of additive manufacturing and its application in the medical industry. His research interests include digital design and manufacturing.

JAN HOLMSTRÖM is currently a Professor of operations management with Aalto University, Helsinki, Finland. He is also an Expert in supply chain management and design science research. He has published extensively on the improvement of operations in industrial, project, and retail supply chain contexts.

Low-tech solutions for the COVID-19 supply chain crisis

3D printing in COVID-19: Productivity estimation of the most promising open source solutions in emergency situations

Viability of intertwined supply networks: Extending the supply chain resilience angles towards survivability. A position paper motivated by COVID-19 outbreak

The global rise of 3D printing during the COVID-19 pandemic

Additive Manufacturing-General Principles-Terminology, Standard ISO/ASTM 2015. ISO/ASTM 52900: 2015 (ASTM F2792)

The additive manufacturing innovation: A range of implications

Rapid manufacturing in the spare parts supply chain: Alternative approaches to capacity deployment

Envisioning e-logistics developments: Making spare parts in situ and on demand: State of the art and guidelines for future developments

Supply chain game changers-mega, nano, and virtual trends-and forces that impede supply chain design (i.E., building a winning team)

Rapid prototyping in humanitarian aid to manufacture last mile vehicles spare parts: An implementation plan

3D Printed Test Swbs for Covid-19 Testing

A novel classification and online platform for planning and documentation of medical applications of additive manufacturing

Sustainability outcomes through direct digital manufacturing-based operational practices: A design theory approach

Experiential learning theory: A dynamic, holistic approach to management learning, education and development,'' in The SAGE Handbook of Management Learning, Education and Development

Defining supply chain management

Supply Chain Operating Reference (SCOR) Model. Accessed

Supply Chain Management Strategy, Planning, and Operation. Global Edition

The Fourth Industrial Revolution

Digital supply chain: Literature review and a proposed framework for future research

Building a digital twin for additive manufacturing through the exploitation of blockchain: A case analysis of the aircraft industry

From rapid prototyping to home fabrication: How 3D printing is changing business model innovation

Additive manufacturing in offsite repair of consumer electronics

Additive manufacturing's impact and future in the aviation industry

Additive manufacturing of biomedical implants: A feasibility assessment via supply-chain cost analysis

Additive fabrication technologies applied to medicine and health care: A review

Additive manufacturing for consumer-centric business models: Implications for supply chains in consumer goods manufacturing

Simulation based method considering design for additive manufacturing and supply chain: An empirical study of lamp industry

Make disruptive technological change happen-The case of additive manufacturing

The impact of additive manufacturing on supply chains

Analysis of barriers to implement additive manufacturing technology in the Indian automotive sector

Challenges to implementing additive manufacturing in globalised production environments

Economic implications of additive manufacturing and the contribution of MIS

Additive manufacturing and its societal impact: A literature review

Economic implications of 3D printing: Market structure models in light of additive manufacturing revisited

Impact of additive manufacturing technology adoption on supply chain management processes and components

Possibilities of preoperative medical models made by 3D printing or additive manufacturing

Patient-specific reconstruction with 3D modeling and DMLS additive manufacturing

Shrinking the supply chain for implantable coronary stent devices

Additive manufacturing: A game changer in supply chain design

A global sustainability perspective on 3D printing technologies

Digital manufacturing-driven transformations of service supply chains for complex products

The direct digital manufacturing (r)evolution: Definition of a research agenda

Additive manufacturing and sustainability: An exploratory study of the advantages and challenges

3D printing disrupts manufacturing: how economies of one create new rules of competition

The disruptive impact of additive manufacturing on supply chains: A literature study, conceptual framework and research agenda

E-commerce channels for additive manufacturing: An exploratory study

Additive manufacturing: A framework for implementation

The adoption process and impact of additive manufacturing on manufacturing systems

3D printing services: Classification, supply chain implications and research agenda

Additive manufacturing scenarios for distributed production of spare parts

Additive manufacturing in the spare parts supply chain

3D printing and its disruptive impacts on supply chains of the future

Decision support for additive manufacturing deployment in remote or austere environments

Additive manufacturing in the spare parts supply chain: Hub configuration and technology maturity

Click here to print a maker movement supply chain: How invention and entrepreneurship will disrupt supply chain design

Case Study Research: Design and Methods

Technical Description FORMIGA P 100

Directions in scenario planning literature-A review of the past decades

Three decades of scenario planning in shell

How to do strategic supply-chain planning

Fuse 1 Technical Specifications

Cost estimation for rapid manufacturing-laser sintering production for low to medium volumes

To kit or not to kit: Analysing the value of model-based kitting for additive manufacturing

DHL Express

3D printing the future: Scenarios for supply chains reviewed

Zuyd University of Applied Sciences-Maastricht. He is currently working with the Brightlands Institute for Supply Chain Innovation (BISCI), Zuyd University of Applied Sciences-Maastricht. His research interests include supply chain innovation